|
|
Blood, 15 June 2007, Vol. 109, No. 12, pp. 5390-5398.
Prepublished online as a Blood First Edition Paper on February 27, 2007; DOI 10.1182/blood-2006-12-061812.
 Previous Article | Next Article 
Submitted December 7, 2006
Accepted February 16, 2007
CD38/CD19: a lipid raft dependent signaling complex in human B cells
Silvia Deaglio, Tiziana Vaisitti, Richard Billington, Luciana Bergui, Paola Omede', Armando A Genazzani, and Fabio Malavasi*
Department of Genetics, Biology and Biochemistry, University of Torino Medical School, Torino, Italy
Research Center on Experimental Medicine (CeRMS), University of Torino Medical School, Torino, Italy
DiSCAFF and the DFB Center, University of Eastern Piedmont, Novara, Italy
Division of Hematology, Department of Medicine & Experimental Oncology, S. Giovanni Battista Hospital, Torino, Italy
* Corresponding author; email: fabio.malavasi{at}unito.it.
The present work deals with the mechanisms of signal transduction mediated via CD38 in normal and neoplastic human B lymphocytes. The results indicate that CD38 is a receptor and that CD38-mediated signals are tightly regulated at three distinct levels. The first concerns the structural organization of CD38, which is clearly divided into monomeric and dimeric forms. The second level of regulation is based on the dynamic localization of CD38 molecules in lipid microdomains within the plasma membrane. Lateral associations with other proteins, namely with the CD19/CD81 complex determine the third level of control. Raft localization and association with the CD19 complex are pre-requisites for CD38-mediated signals in tonsillar B cells and in continuous lines. Lastly, the results indicate that lipid microdomain disruption and silencing of CD19 directly impacts on CD38's ability to mediate Ca2+ fluxes, while leaving its surface expression unchanged. CD38 is also an enzyme capable of producing several calcium-mobilizing metabolites including cyclic adenosine diphosphate ribose (cADPR). Our inability to identify a correlation between the production of cADPR and the receptorial functions support the hypothesis that CD38 is a pleiotropic molecule, whose behavior as a receptor is independent from its enzymatic activity.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S.-J. Jia, S. Jin, F. Zhang, F. Yi, W. L. Dewey, and P.-L. Li
Formation and function of ceramide-enriched membrane platforms with CD38 during M1-receptor stimulation in bovine coronary arterial myocytes
Am J Physiol Heart Circ Physiol,
October 1, 2008;
295(4):
H1743 - H1752.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Malavasi, S. Deaglio, A. Funaro, E. Ferrero, A. L. Horenstein, E. Ortolan, T. Vaisitti, and S. Aydin
Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology
Physiol Rev,
July 1, 2008;
88(3):
841 - 886.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Rodriguez-Alba, M. E. Moreno-Garcia, C. Sandoval-Montes, V. H. Rosales-Garcia, and L. Santos-Argumedo
CD38 induces differentiation of immature transitional 2 B lymphocytes in the spleen
Blood,
April 1, 2008;
111(7):
3644 - 3652.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. N. Damle, S. Temburni, C. Calissano, S. Yancopoulos, T. Banapour, C. Sison, S. L. Allen, K. R. Rai, and N. Chiorazzi
CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells
Blood,
November 1, 2007;
110(9):
3352 - 3359.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
